These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Unexpected improvement in levodopa-induced dyskinesia and on-off phenomena after introduction of memantine for treatment of Parkinson's disease dementia. Vidal EI; Fukushima FB; Valle AP; Villas Boas PJ J Am Geriatr Soc; 2013 Jan; 61(1):170-2. PubMed ID: 23311565 [No Abstract] [Full Text] [Related]
5. [Dementia in Parkinson's disease]. Halvorsen Ø; Tysnes OB Tidsskr Nor Laegeforen; 2007 Oct; 127(19):2517-20. PubMed ID: 17925819 [TBL] [Abstract][Full Text] [Related]
6. [Dementia--common, difficult to treat complication in Parkinson disease. Early diagnosis valuable--cholinesterase inhibitors can give better quality of life]. Lökk J; Winblad B Lakartidningen; 2006 Feb 15-21; 103(7):451-5. PubMed ID: 16535872 [No Abstract] [Full Text] [Related]
13. Postmenopausal estrogen use and Parkinson's disease with and without dementia. Marder K; Tang MX; Alfaro B; Mejia H; Cote L; Jacobs D; Stern Y; Sano M; Mayeux R Neurology; 1998 Apr; 50(4):1141-3. PubMed ID: 9566410 [TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment in Parkinson's disease. Girotti F; Marano R; Grazzi L; Scigliano G; Caraceni T J Neural Transm Suppl; 1986; 22():163-70. PubMed ID: 3465870 [TBL] [Abstract][Full Text] [Related]
15. [Pathogenetic and therapeutic aspects of dementia in Parkinson's disease]. Damulin IV Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(2):73-7. PubMed ID: 19385124 [No Abstract] [Full Text] [Related]
16. [Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences]. Drach LM Med Monatsschr Pharm; 2011 Feb; 34(2):47-52; quiz 53-4. PubMed ID: 21428015 [TBL] [Abstract][Full Text] [Related]
18. [Emotional and cognitive disorders in Parkinson disease]. Arsland D; Larsen JP Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3959-63. PubMed ID: 9830342 [TBL] [Abstract][Full Text] [Related]
19. [Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing]. Larsson A Lakartidningen; 2006 May 10-16; 103(19):1537; discussion 1537-8. PubMed ID: 16805251 [No Abstract] [Full Text] [Related]
20. Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Wesnes KA; McKeith I; Edgar C; Emre M; Lane R Neurology; 2005 Nov; 65(10):1654-6. PubMed ID: 16301500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]